-
1
-
-
84861338466
-
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
-
Meucci G, Fasoli R, Saibeni S, et al. Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study. Inflamm Bowel Dis. 2012;18:1006-1010.
-
(2012)
Inflamm Bowel Dis.
, vol.18
, pp. 1006-1010
-
-
Meucci, G.1
Fasoli, R.2
Saibeni, S.3
-
2
-
-
79957452795
-
Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis
-
e483
-
Ardizzone S, Cassinotti A, Duca P, et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis. Clin Gastroenterol Hepatol. 2011;9:483-489. e483.
-
(2011)
Clin Gastroenterol Hepatol.
, vol.9
, pp. 483-489
-
-
Ardizzone, S.1
Cassinotti, A.2
Duca, P.3
-
3
-
-
34547503869
-
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
-
Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412-422.
-
(2007)
Gastroenterology
, vol.133
, pp. 412-422
-
-
Froslie, K.F.1
Jahnsen, J.2
Moum, B.A.3
-
4
-
-
70349418632
-
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
-
quiz 1520
-
Sandborn WJ, Rutgeerts P, Feagan BG, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137:1250-1260. quiz 1520.
-
(2009)
Gastroenterology
, vol.137
, pp. 1250-1260
-
-
Sandborn, W.J.1
Rutgeerts, P.2
Feagan, B.G.3
-
5
-
-
67049137968
-
Clinical course during the first 10 years of ulcerative colitis: Results from a population-based inception cohort (IBSEN Study)
-
Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
-
(2009)
Scand J Gastroenterol.
, vol.44
, pp. 431-440
-
-
Solberg, I.C.1
Lygren, I.2
Jahnsen, J.3
-
6
-
-
0026065160
-
Microscopic activity in ulcerative colitis: What does it mean?
-
Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174-178.
-
(1991)
Gut
, vol.32
, pp. 174-178
-
-
Riley, S.A.1
Mani, V.2
Goodman, M.J.3
-
7
-
-
10744221150
-
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
-
Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
-
(2004)
Gastroenterology
, vol.126
, pp. 451-459
-
-
Rutter, M.1
Saunders, B.2
Wilkinson, K.3
-
8
-
-
80053130407
-
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
-
Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194-1201.
-
(2011)
Gastroenterology
, vol.141
, pp. 1194-1201
-
-
Colombel, J.F.1
Rutgeerts, P.2
Reinisch, W.3
-
9
-
-
34848893583
-
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
-
quiz 1340-1091
-
Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099-1105. quiz 1340-1091.
-
(2007)
Gastroenterology
, vol.133
, pp. 1099-1105
-
-
Gupta, R.B.1
Harpaz, N.2
Itzkowitz, S.3
-
10
-
-
0033013167
-
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
-
Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50-54.
-
(1999)
Scand J Gastroenterol.
, vol.34
, pp. 50-54
-
-
Roseth, A.G.1
Schmidt, P.N.2
Fagerhol, M.K.3
-
11
-
-
0033795259
-
A simple method for assessing intestinal inflammation in Crohn's disease
-
Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506-513.
-
(2000)
Gut
, vol.47
, pp. 506-513
-
-
Tibble, J.1
Teahon, K.2
Thjodleifsson, B.3
-
12
-
-
14544308315
-
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
-
Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut. 2005;54:364-368.
-
(2005)
Gut
, vol.54
, pp. 364-368
-
-
Costa, F.1
Mumolo, M.G.2
Ceccarelli, L.3
-
13
-
-
0034234796
-
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
-
Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119:15-22.
-
(2000)
Gastroenterology
, vol.119
, pp. 15-22
-
-
Tibble, J.A.1
Sigthorsson, G.2
Bridger, S.3
-
14
-
-
49349114912
-
Can calprotectin predict relapse risk in inflammatory bowel disease?
-
D'Inca R, Dal Pont E, Di Leo V, et al. Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol. 2008;103:2007-2014.
-
(2008)
Am J Gastroenterol.
, vol.103
, pp. 2007-2014
-
-
D'Inca, R.1
Dal Pont, E.2
Di Leo, V.3
-
15
-
-
70349484242
-
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
-
Gisbert JP, Bermejo F, Perez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis. 2009;15:1190-1198.
-
(2009)
Inflamm Bowel Dis.
, vol.15
, pp. 1190-1198
-
-
Gisbert, J.P.1
Bermejo, F.2
Perez-Calle, J.L.3
-
16
-
-
77952104443
-
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
-
Garcia-Sanchez V, Iglesias-Flores E, Gonzalez R, et al. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J Crohns Colitis. 2010;4:144-152.
-
(2010)
J Crohns Colitis.
, vol.4
, pp. 144-152
-
-
Garcia-Sanchez, V.1
Iglesias-Flores, E.2
Gonzalez, R.3
-
17
-
-
84862524860
-
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
-
D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218-2224.
-
(2012)
Inflamm Bowel Dis.
, vol.18
, pp. 2218-2224
-
-
D'Haens, G.1
Ferrante, M.2
Vermeire, S.3
-
18
-
-
63649130839
-
Mucosal vascular pattern in ulcerative colitis: Observations using narrow band imaging colonoscopy with special reference to histologic inflammation
-
Kudo T, Matsumoto T, Esaki M, et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation. Int J Colorectal Dis. 2009;24:495-501.
-
(2009)
Int J Colorectal Dis.
, vol.24
, pp. 495-501
-
-
Kudo, T.1
Matsumoto, T.2
Esaki, M.3
-
19
-
-
0030670836
-
Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis
-
Matsumoto T, Kuroki F, Mizuno M, et al. Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis. Gastrointest Endosc. 1997;46:400-405.
-
(1997)
Gastrointest Endosc.
, vol.46
, pp. 400-405
-
-
Matsumoto, T.1
Kuroki, F.2
Mizuno, M.3
-
20
-
-
0036781083
-
Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis
-
Fujiya M, Saitoh Y, Nomura M, et al. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc. 2002;56:535-542.
-
(2002)
Gastrointest Endosc.
, vol.56
, pp. 535-542
-
-
Fujiya, M.1
Saitoh, Y.2
Nomura, M.3
-
21
-
-
79955577193
-
Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis
-
Esaki M, Kubokura N, Kudo T, et al. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig Endosc. 2011;23(suppl 1):140-142.
-
(2011)
Dig Endosc.
, vol.23
, Issue.SUPPL. 1
, pp. 140-142
-
-
Esaki, M.1
Kubokura, N.2
Kudo, T.3
-
22
-
-
33845463326
-
Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis
-
Nishio Y, Ando T, Maeda O, et al. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut. 2006;55:1768-1773.
-
(2006)
Gut
, vol.55
, pp. 1768-1773
-
-
Nishio, Y.1
Ando, T.2
Maeda, O.3
-
23
-
-
0023521441
-
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
-
(1987)
N Engl J Med.
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
24
-
-
73049175547
-
The value of rectal biopsy in the diagnosis of ulcerative colitis
-
Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961;30:393-407.
-
(1961)
Q J Med.
, vol.30
, pp. 393-407
-
-
Matts, S.G.1
-
25
-
-
0035166741
-
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
-
Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13-20.
-
(2001)
Gastroenterology
, vol.120
, pp. 13-20
-
-
Bitton, A.1
Peppercorn, M.A.2
Antonioli, D.A.3
-
26
-
-
33646778482
-
The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications
-
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
-
(2006)
Gut
, vol.55
, pp. 749-753
-
-
Satsangi, J.1
Silverberg, M.S.2
Vermeire, S.3
-
27
-
-
0037379754
-
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
-
Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.
-
(2003)
Gastroenterology
, vol.124
, pp. 880-888
-
-
Kiesslich, R.1
Fritsch, J.2
Holtmann, M.3
-
28
-
-
79955555545
-
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease
-
e1812
-
Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140:1817-1826. e1812.
-
(2011)
Gastroenterology
, vol.140
, pp. 1817-1826
-
-
Lewis, J.D.1
-
29
-
-
72549104759
-
Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes
-
Schoepfer AM, Beglinger C, Straumann A, et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851-1858.
-
(2009)
Inflamm Bowel Dis.
, vol.15
, pp. 1851-1858
-
-
Schoepfer, A.M.1
Beglinger, C.2
Straumann, A.3
-
30
-
-
57449093379
-
Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis
-
Osada T, Ohkusa T, Okayasu I, et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol. 2008;23(suppl 2):S262-S267.
-
(2008)
J Gastroenterol Hepatol.
, vol.23
, Issue.SUPPL. 2
-
-
Osada, T.1
Ohkusa, T.2
Okayasu, I.3
-
31
-
-
39849086660
-
Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis
-
Xiang JY, Ouyang Q, Li GD, et al. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol. 2008;14:53-57.
-
(2008)
World J Gastroenterol.
, vol.14
, pp. 53-57
-
-
Xiang, J.Y.1
Ouyang, Q.2
Li, G.D.3
-
32
-
-
10844282782
-
PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
-
Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96.
-
(2005)
Gut
, vol.54
, pp. 91-96
-
-
Loftus Jr., E.V.1
Harewood, G.C.2
Loftus, C.G.3
-
33
-
-
62949097145
-
Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps
-
Rex DK. Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps. Gastroenterology. 2009;136:1174-1181.
-
(2009)
Gastroenterology
, vol.136
, pp. 1174-1181
-
-
Rex, D.K.1
-
34
-
-
84862880940
-
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease
-
Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut. 2012;61:1146-1153.
-
(2012)
Gut
, vol.61
, pp. 1146-1153
-
-
Kiesslich, R.1
Duckworth, C.A.2
Moussata, D.3
|